Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01629316 · ClinicalTrials.gov registry record · NA

Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX

A NA study of HIV Infection, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
381
Enrollment target
2
Study locations

NCT01629316: Completed NA study of HIV Infection, sponsored by University of North Carolina, Chapel Hill.

NCT01629316 is a NA study of HIV Infection that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 381 participants, above the 238-participant average among 73 other HIV Infection trials with a reported enrollment target (60% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01629316, a NA study of HIV Infection, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
381 participants
Enrollment target
2
Study locations

Study Summary

Purpose: The purpose of this study is to determine if a comprehensive intervention supporting seek-test-and-treat results in a significant reduction in the potential for HIV-infected prisoners to transmit their virus after release from prison. Aim 2: Compare the effect of standard prison test-and-treat (sTNT) with the TNT-imPACT (imPACT) intervention on viral load 24 weeks following prison release. Aim 3: Describe and model secondary outcomes, comparing them between sTNT and TNT-imPACT study arms. These outcomes include post-release HIV transmission risk behaviors, incident STIs, adherence to ART, medical care appointments, emergence of ART resistance mutations, and predicted HIV transmission events.

Conditions Studied

Interventions

  • BEHAVIORAL Text reminders, counseling, and link coordination
  • BEHAVIORAL Standard of care - control arm

Study Locations (2)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Texas

  • Texas Christian University - Fort Worth

Trial Details

FieldValue
Enrollment Target 381 participants
Start Date 2012-03
Est. Completion 2015-05
Phase NA

What the finished NCT01629316 record still lists

NCT01629316 is an interventional study that assigns participants to a tested intervention. The registered 381 participants enrollment target is mid-sized for trials with a published cap, above the 238-participant average among 73 other HIV Infection trials with a reported enrollment target (60% higher).

The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 2 interventions - of which Text reminders, counseling, and link coordination is the first listed.

NCT01629316 reports a single indexed study location in North Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT01629316 about?

NCT01629316 is a clinical study titled "Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX". Purpose: The purpose of this study is to determine if a comprehensive intervention supporting seek-test-and-treat results in a significant reduction in the potential for HIV-infected prisoners to transmit their virus after release from prison. Aim 2: Compare the effect of standard prison test-and-t...

What is the current status of trial NCT01629316?

This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2012-03. Estimated completion is 2015-05.

What conditions does trial NCT01629316 study?

This clinical trial studies the following conditions: HIV Infection.

What interventions are being tested in trial NCT01629316?

The interventions under investigation include: Text reminders, counseling, and link coordination (BEHAVIORAL), Standard of care - control arm (BEHAVIORAL).

Who is sponsoring clinical trial NCT01629316?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01629316 being conducted?

This trial has 2 study locations across North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01629316's enrollment target sits among peer trials

381 11th of 73 higher than 63 of 73 other HIV Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05677490 · 382 participants · Phase 3

    mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • NCT06196008 · 382 participants · NA

    Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

  • NCT07100990 · 382 participants · Phase 3

    Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

  • NCT04560673 · 380 participants · Phase 2

    Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01629316, the US trial registry maintained by the National Library of Medicine. NCT01629316 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.